This surprising drug may soon be used to treat panic disorder
Key Points:
- A Brazilian study found that low doses of minocycline, a common antibiotic with anti-inflammatory properties, may help reduce symptoms of panic disorder by targeting brain inflammation.
- In animal tests, minocycline reduced panic-like behaviors and decreased activity in the brain region associated with panic responses, the locus coeruleus.
- A small human trial showed minocycline lowered pro-inflammatory markers and improved anxiety symptoms in panic disorder patients, suggesting a different mechanism than traditional benzodiazepines.
- Unlike benzodiazepines, which carry risks of addiction and serious side effects, minocycline is generally safe and was used at lower doses that may minimize side effects and antibiotic resistance concerns.
- Researchers emphasize the need for larger clinical trials before minocycline can be prescribed for panic disorder, but the findings offer promising potential for new inflammation-targeting treatments.